A client received midazolam 2 mg and morphine sulfate 4 mg for a liver biopsy. After the procedure, the nurse positions the client on the right side and monitors the vital signs. Which is the physiological reason for the nurse's intervention?

Intermittent claudication is a common symptom experienced by individuals with peripheral artery disease (PAD). It occurs due to the underlying pathophysiology of arterial occlusion and ischemia during physical activity. Here's why option C is the correct choice:

A) Reduced blood flow occurs when legs are elevated:

This statement is not accurate regarding the pathophysiology of intermittent claudication in PAD. When legs are elevated, gravity assists venous return, which may actually improve blood flow temporarily. However, intermittent claudication occurs during activity, not when the legs are elevated.

B) Reddened color occurs when the feet are dependent:

This statement is unrelated to the pathophysiology of intermittent claudication. Redness when the feet are dependent may suggest venous insufficiency rather than arterial occlusion characteristic of PAD.

C) Arterial occlusion causes ischemic pain during activity:

Correct. Intermittent claudication is caused by inadequate blood flow to the muscles during physical activity due to arterial occlusion in PAD. As the demand for oxygen increases during exercise, the narrowed arteries cannot supply sufficient blood flow, leading to ischemic pain in the affected muscles. This pain typically resolves with rest and recurs upon resuming activity.

D) Reduction in blood supply leads to muscle atrophy:

Muscle atrophy may occur in severe cases of PAD with chronic ischemia, but it is not the primary cause of intermittent claudication. Intermittent claudication is primarily attributed to inadequate blood flow during activity, which results in ischemic pain rather than muscle atrophy.

Tumor lysis syndrome (TLS) is a potentially life-threatening oncologic emergency characterized by the rapid release of intracellular contents into the bloodstream following the destruction of cancer cells. This release can lead to metabolic disturbances, including hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia. Here's how the child's laboratory results are indicative of tumor lysis syndrome:

A) Wilm's tumor:

Wilms tumor is a type of kidney cancer that primarily affects children. However, it typically does not cause the metabolic disturbances seen in tumor lysis syndrome. Laboratory abnormalities in Wilms tumor are generally related to renal dysfunction and may include hematuria and proteinuria.

B) Tumor lysis syndrome:

Correct. Tumor lysis syndrome occurs when chemotherapy or radiation therapy causes a rapid breakdown of cancer cells, leading to the release of intracellular contents such as potassium, phosphorus, and uric acid into the bloodstream. The elevated potassium and phosphorus levels seen in the child's laboratory results are consistent with tumor lysis syndrome. Hyperkalemia (elevated potassium) and hyperphosphatemia (elevated phosphorus) are common metabolic disturbances in tumor lysis syndrome.

C) Superior vena cava syndrome:

Superior vena cava syndrome occurs when the superior vena cava, a major vein that carries blood from the upper body to the heart, becomes partially or completely obstructed. This obstruction can lead to symptoms such as facial swelling, dyspnea, and dilated neck veins. While superior vena cava syndrome may occur in cancer patients, it does not typically cause the metabolic disturbances seen in the child's laboratory results.

D) Hyperleukocytosis:

Hyperleukocytosis refers to an extremely high white blood cell count, which can occur in leukemia. While leukemia can lead to metabolic abnormalities, the child's laboratory results, particularly the elevated potassium and phosphorus levels, are more indicative of tumor lysis syndrome than hyperleukocytosis.